[SLRX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
06-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -5.99%
YoY- 12.27%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 246 179 283 414 336 243 299 -12.22%
PBT -9,052 -8,223 -8,029 -9,332 -8,805 -8,268 -7,900 9.52%
Tax 0 0 -74 0 0 0 -112 -
NP -9,052 -8,223 -8,029 -9,332 -8,805 -8,268 -7,900 9.52%
Tax Rate - - - - - - - -
Total Cost 9,297 8,402 8,312 9,746 9,140 8,511 8,199 8.76%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -3,687.09 -4,604.73 -2,837.10 -2,256.31 -2,624.15 -3,408.99 -2,642.14 24.95%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -313.66 -287.22 -284.43 -335.48 -321.24 -306.27 -297.08 3.69%
EPS Diluted -313.66 -287.22 -284.43 -335.48 -321.24 -306.27 -297.08 3.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.